Data
Click on Protocol Number of interest to view study-related documentation or download data files.
(DTMC data files are under development.)
Division Sort ascending | Study Number | Title | Investigator(s) | Release Date |
---|---|---|---|---|
CTN | NIDA-CTN-0001 | Buprenorphine/Naloxone versus Clonidine for Inpatient Opiate Detoxification | Walter Ling, M.D. | May 08, 2006 |
CTN | NIDA-CTN-0002 | Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification | Walter Ling, M.D. | Jul 26, 2006 |
CTN | NIDA-CTN-0003 | Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules | Walter Ling, M.D. | May 29, 2008 |
CTN | NIDA-CTN-0027 | Starting Treatment with Agonist Replacement Therapies (START) | Walter Ling, M.D. | Jun 06, 2012 |
CTN | NIDA-CTN-0030 | A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence | Walter Ling, M.D., Roger Weiss, M.D. | Jun 22, 2011 |
CTN | NIDA-CTN-0030A3 | Long-Term Follow-Up to CTN-0030 (A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence) | Roger Weiss, M.D., Jennifer Sharpe Potter, Ph.D. | Aug 22, 2014 |
CTN | NIDA-CTN-0059 | The TAPS Tool: Screen and Brief Assessment Tool Validation Study | Robert P Schwartz, M.D., Li-Tzy Wu, Psy.D., Jennifer McNeely, M.D. | Sep 14, 2017 |
CTN | NIDA-CTN-0051 | Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment | John Rotrosen, M.D. | Jan 12, 2018 |
CTN | NIDA-CTN-0075 | Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder | Li-Tzy Wu, Psy.D., Paolo Mannelli, MD | Feb 16, 2023 |
CTN | NIDA-CTN-0093 | Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool | Gerald Cochran, PhD, T. John Winhusen, Ph.D. | Apr 13, 2023 |